Senior Leadership

高层领导

基本信息

批准号：
8557639
负责人：
ROY A. JENSEN
金额：
$ 67.36万
依托单位：
UNIVERSITY OF KANSAS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-07-11 至 2017-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8557639
关键词：
Academia Adoption Antineoplastic Agents Area Award Basic Science Budgets Cancer Center Cancer Center Support Grant Cancer Research Project Clinical Clinical Sciences Clinical Trials Clinical and Translational Science Awards Communities Counseling Development Diagnosis Disease Environment Equipment Fostering Funding Goals Government Grant Growth and Development function Hematopoietic Neoplasms Industry Institution Instruction Kansas Laboratories Leadership Malignant Neoplasms Medicine Oncologist Pharmacotherapy Phase Phase I Clinical Trials Play Policies Population Sciences Procedures Research Research Personnel Resource Allocation Resource Sharing Resources Role Services Technology Translational Research Universities Vision base cancer prevention cost effectiveness drug development drug discovery experience frontier implementation research meetings member novel therapeutics oncology population based programs success survivorship working group

项目摘要

PROJECT SUMMARY (See instructions): The University of Kansas Cancer Center Senior Leadership team is led by the Director, who is assisted by the Deputy Director, the Chief Operating Officer, and seven Associate Directors. The team meets bi-monthly, to discuss matters pertaining to the four research programs and their scientific progress; the four shared resources and their cost effectiveness, utilization, and quality; ad hoc budget requests from Cancer Center members; space allocation requests; new shared resources or shared equipment requests; and set all Cancer Center policies and procedures. The Senior Leaders also meet regularly in the context of the Cancer Center's Leadership Council (every other month). Program Leader (every other month) and/or Shared Resource meetings (quarterly). Collectively the Senior Leadership has ultimate responsibility for identifying, developing, and implementing intra- and inter-programmatic collaborative research opportunities. Each Senior Leader contributes a special expertise that collectively provides the Director counsel related to the development and growth of the Cancer Center's clinical trial portfolio, shared resources, basic, translational, clinical and population sciences, and research base and funding resources.

项目摘要（请参阅说明）：堪萨斯大学癌症中心高级领导团队由董事领导，董事由副主任，首席运营官和七名副董事在协助下。团队每两月开会，讨论与四个研究计划及其科学进步有关的事情；这四个共享资源及其成本效益，利用和质量；癌症中心成员的临时预算要求；空间分配请求；新的共享资源或共享设备请求；并设定所有癌症中心的政策和程序。高级领导人还定期在癌症中心领导委员会（每隔一个月）开会。计划负责人（每隔一个月）和/或共享资源会议（季度）。总体而言，高级领导人有最终的责任，以识别，开发和实施跨编程间协作研究机会。每个高级领导者都贡献了一个特殊的专业知识，该专业知识共同提供与癌症中心临床试验组合，共享资源，基础，翻译，临床和人口科学以及研究基础和资金资源的临床试验组合，共享资源，基础，翻译，临床和人口的发展和增长有关的董事律师。